Leuthold Group LLC Reduces Stock Position in Humana Inc. (NYSE:HUM)

Leuthold Group LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 56.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,050 shares of the insurance provider’s stock after selling 10,227 shares during the period. Leuthold Group LLC’s holdings in Humana were worth $3,008,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in HUM. CarsonAllaria Wealth Management Ltd. lifted its holdings in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Hantz Financial Services Inc. purchased a new stake in Humana in the 2nd quarter valued at $35,000. Family Firm Inc. acquired a new stake in Humana during the 2nd quarter worth $37,000. Carolinas Wealth Consulting LLC grew its position in Humana by 274.1% during the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares during the last quarter. Finally, Riverview Trust Co acquired a new position in Humana in the second quarter valued at $44,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Piper Sandler started coverage on Humana in a report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price target for the company. JPMorgan Chase & Co. lifted their price objective on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Truist Financial boosted their target price on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Oppenheimer raised their price target on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $398.70.

Humana Stock Performance

Humana stock opened at $315.29 on Thursday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The stock has a fifty day moving average of $360.50 and a two-hundred day moving average of $346.16. The company has a market capitalization of $37.99 billion, a price-to-earnings ratio of 19.63, a PEG ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $8.94 EPS. On average, analysts anticipate that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.12%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.